Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Canesten (Topical)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Canesten 1% cream
1310020H0BBAAAB
|
Canesten (Topical) | Clotrimazole | Skin | 4,438 |
|
Canesten 1% solution
1310020H0BBABAA
|
Canesten (Topical) | Clotrimazole | Skin | 604 |
|
Canesten Dermatological 1% spray
1310020H0BBACAE
|
Canesten (Topical) | Clotrimazole | Skin | 121 |
|
Canesten Antifungal cream
1310020H0BBAHAB
|
Canesten (Topical) | Clotrimazole | Skin | 118 |
|
Canesten Athlete's Foot 1% cream
1310020H0BBAEAB
|
Canesten (Topical) | Clotrimazole | Skin | 32 |
|
Canesten AF Dual Action 1% powder
1310020H0BBAFAD
|
Canesten (Topical) | Clotrimazole | Skin | No data available |
|
Canesten AF Dual Action 1% spray
1310020H0BBAGAE
|
Canesten (Topical) | Clotrimazole | Skin | No data available |
|
Canesten Dermatological 1% powder
1310020H0BBADAD
|
Canesten (Topical) | Clotrimazole | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.